Pam Belluck's article highlights the experience of Amanda Sifford, an A.L.S. patient undergoing the newly approved therapy tofersen in Miami, which has led to notable improvements in her breathing and mobility, raising hope for others with this debilitating disease despite its severe side effects and the challenges of treating various A.L.S. symptoms. #ALS #NeurodegenerativeDisorders #GeneTherapy #US #CA
